Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug discovery
Biotech
iBio champions AI-fueled obesity pivot as 1st asset hits clinic
Upon finally reaching the clinic, iBio feels vindicated about the artificial intelligence-powered discovery platform it picked up in 2022.
Fraiser Kansteiner
Jun 26, 2026 5:00am
With $15M, BI becomes latest to buy into Immunai’s AI platform
Jun 25, 2026 9:00am
Insilico lands backloaded $2.5B AI deal with SK Biopharm
Jun 22, 2026 12:30am
Jazz, AbCellera strike TCE discovery and development deal
Jun 17, 2026 7:00am
Altaris scoops up AI drug development outfit for $375M
Jun 16, 2026 12:13pm
Incyte pays Genesis $80M to expand AI-fueled drug discovery pact
May 20, 2026 10:22am
